CurrentEndo
Get Weekly

CurrentEndo coverage · page 4 of 18

Osteoporosis International

Briefs 121–160 of 695 CurrentEndo has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Romosozumab is effective in patients with variants in LRP5, LRP6, or WNT1

    Cohort studyBone & mineral

  2. Osteoporos Int

    Clinical implementation of AI for vertebral fracture detection in CT aligned with fracture liaison services: high prevalence of undiagnosed vertebral fractures

    Cohort studyBone & mineral

  3. Osteoporos Int

    Comparison of traditional and new treatments for fibrous dysplasia: a systematic review and meta-analysis

    Meta-analysisBone & mineral

  4. Osteoporos Int

    Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss

    Cohort studyBone & mineral

  5. Osteoporos Int

    A meta-analysis of smoking and fracture risk to update the FRAX® tool

    Meta-analysisBone & mineral

  6. Osteoporos Int

    The impact of Tai Chi on osteoporosis and osteopenia in middle-aged and elderly adults: a systematic review and meta-analysis of randomized controlled trial

    Meta-analysisBone & mineral

  7. Osteoporos Int

    Clinical utility of one-third radius BMD in a population-based prospective cohort of older adults: Insights from the São Paulo Aging & Health (SPAH) study

    Cohort studyBone & mineral

  8. Osteoporos Int

    Incidence of proximal humerus fracture among older adults in Oslo, Norway varies by country background, marital status, and season

    Cohort studyBone & mineral

  9. Osteoporos Int

    Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson’s disease

    Cohort studyBone & mineral

  10. Osteoporos Int

    Exercise improves quality of life, mental health and pain in people living with osteoporosis: a systematic review and meta-analysis

    Meta-analysisBone & mineral

  11. Osteoporos Int

    Trends of clinical vertebral and hip fractures following local government involvement in fracture prevention from 2015 to 2021 in Kure, Japan

    Cohort studyBone & mineral

  12. Osteoporos Int

    The recurrence of osteoporotic fractures among first- and second-generation immigrants in Sweden

    Cohort studyBone & mineral

  13. Osteoporos Int

    Balancing risks in febrile hip fracture patients: is surgical delay more dangerous than infection?

    Cohort studyBone & mineral

  14. Osteoporos Int

    External validation of the proposed diagnostic criteria for hypophosphatasia in adults of a Spanish cohort

    Diagnostic or prognostic studyBone & mineral

  15. Osteoporos Int

    Psychotropic medication use and bone fracture risk among patients with multiple sclerosis: a real-world study

    Cohort studyBone & mineral

  16. Osteoporos Int

    Effectiveness and safety of bone protective interventions to mitigate bone loss and skeletal fractures experienced by patients with non-metastatic breast cancer: a systematic review and meta-analysis

    Meta-analysisBone & mineral

  17. Osteoporos Int

    “Build better bones”: development, launch, and future directions of a multilingual, user-centered website for osteoporosis management

    Research articleBone & mineral

  18. Osteoporos Int

    State sequence analysis for a deeper understanding of treatment adherence patterns in fragility fracture patients

    Cohort studyBone & mineral

  19. Osteoporos Int

    Longitudinal associations of dietary intake, physical activity, and short-chain fatty acids with bone development in early postmenopausal women

    Secondary analysisReproductive endocrine

  20. Osteoporos Int

    Hypocalcemia following denosumab in osteoporosis: Incidence and risk factors in a Saudi cohort

    Cohort studyBone & mineral

  21. Osteoporos Int

    Fracture risks in patients with arginine vasopressin deficiency: a nationwide matched cohort study

    Cohort studyBone & mineral

  22. Osteoporos Int

    Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trial

    Randomized controlled trialBone & mineral

  23. Osteoporos Int

    Bisphosphonate treatment for secondary osteoporosis in children, youth, and young adults: a systematic review and meta-analysis

    Meta-analysisBone & mineral

  24. Osteoporos Int

    Paternal age is associated with offspring bone health—but not soft tissue composition or fracture: the Vitamin D in Pregnancy Study

    Cohort studyBone & mineral

  25. Osteoporos Int

    Incidence of first and subsequent fractures in multiple myeloma patients: a parallel cohort study using UK CPRD dataset

    Cohort studyBone & mineral

  26. Osteoporos Int

    Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis

    Meta-analysisBone & mineral

  27. Osteoporos Int

    Profiling bone status indices reveals evidence of a low-turnover bone phenotype in type 2 diabetes: findings from the DiaFALL cohort

    Cross-sectional studyT2D & other

  28. Osteoporos Int

    Clinical and economic impact of deep learning-enhanced opportunistic osteoporosis screening using chest radiographs with and without the osteoporosis self-assessment tool for Asians (OSTA)

    Research articleBone & mineral

  29. Osteoporos Int

    Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervention: a randomized controlled trial

    Randomized controlled trialObesity

  30. Osteoporos Int

    Conservative treatments for non-surgically managed osteoporotic vertebral compression fractures: a network meta-analysis of long-term pain and quality of life

    Meta-analysisBone & mineral

  31. Osteoporos Int

    Post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis

    Cohort studyBone & mineral

  32. Osteoporos Int

    Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study

    Cross-sectional studyBone & mineral

  33. Osteoporos Int

    Association between SGLT2 inhibitor use and the risk of vertebral augmentation after initial osteoporotic vertebral fracture in patients with type 2 diabetes

    Cohort study

  34. Osteoporos Int

    Controlling Nutritional Status (CONUT) score as a key predictor of disability following conservative treatment of osteoporotic vertebral fractures

    Case-control studyBone & mineral

  35. Osteoporos Int

    Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)

    Diagnostic or prognostic studyBone & mineral

  36. Osteoporos Int

    A programmatic approach to osteoporosis treatment: insight from a 20-year longitudinal study

    Cohort studyBone & mineral

  37. Osteoporos Int

    Burden of accumulating fragility fractures on health service usage and costs among post-menopausal women

    Cohort studyBone & mineral

  38. Osteoporos Int

    Romosozumab mitigates progression from radiological to symptomatic adjacent-level fractures compared to teriparatide

    Cohort studyBone & mineral

  39. Osteoporos Int

    Bone density and remodeling after discontinuation of sequential therapy for premenopausal idiopathic osteoporosis

    Cohort studyBone & mineral

  40. Osteoporos Int

    Changes in treatment eligibility with race-neutral US FRAX would be modest: estimates using the National Health and Nutrition Examination Survey (NHANES)

    Cross-sectional studyBone & mineral

All 695 Briefs in ExploreShowing Briefs 121–160 of 695, newest first